Publication | Closed Access

Quantitative immunoproteomics analysis reveals novel MHC class I presented peptides in cisplatin-resistant ovarian cancer cells

Cancer ImmunosurveillanceMhc ClassPeptide LibraryImmunologyImmunoeditingPathologyPeptide TherapeuticAntigen ProcessingImmunotherapyMedicineCancer ResearchTumor MicroenvironmentTumor BiologyOvarian Cancer